Notice of Meeting of the EPA Children's Health Protection Advisory Committee (CHPAC), 60456 [2020-21143]

Download as PDF 60456 Federal Register / Vol. 85, No. 187 / Friday, September 25, 2020 / Notices [FRL–10015–06–OA] Notice of Meeting of the EPA Children’s Health Protection Advisory Committee (CHPAC) Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: Pursuant to the provisions of the Federal Advisory Committee Act, notice is hereby given that the next meeting of the Children’s Health Protection Advisory Committee (CHPAC) will be held virtually October 22, 2020. The CHPAC advises the Environmental Protection Agency (EPA) on science, regulations and other issues relating to children’s environmental health. DATES: October 22, 2020 from 2 p.m. to 5 p.m. ADDRESSES: The meeting will take place virtually. If you want to listen to the meeting or provide comments, please email louie.nica@epa.gov for further details. FOR FURTHER INFORMATION CONTACT: Nica Louie, Office of Children’s Health Protection, U.S. EPA, MC 1107T, 1200 Pennsylvania Avenue NW, Washington, DC 20460, (202) 564–7633 or louie.nica@epa.gov. SUPPLEMENTARY INFORMATION: The meetings of the CHPAC are open to the public. An agenda will be posted to https://www.epa.gov/children/ childrens-health-protection-advisorycommittee-chpac. Access and Accommodations: For information on access or services for individuals with disabilities, please contact Nica Louie at 202–564–7633 or louie.nica@epa.gov. SUMMARY: Dated: September 16, 2019. Nica Mostaghim, Environmental Health Scientist. [FR Doc. 2020–21143 Filed 9–24–20; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY khammond on DSKJM1Z7X2PROD with NOTICES [EPA–HQ–OPPT–2019–0237; FRL–10014– 87] Cyclic Aliphatic Bromide Cluster (HBCD); Final Toxic Substances Control Act (TSCA) Risk Evaluation; Notice of Availability Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: VerDate Sep<11>2014 18:25 Sep 24, 2020 Jkt 250001 The Environmental Protection Agency (EPA) is announcing the availability of the final Toxic Substances Control Act (TSCA) risk evaluation of Cyclic Aliphatic Bromide Cluster (HBCD). The purpose of conducting risk evaluations under TSCA is to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment under the conditions of use, including an unreasonable risk to a relevant potentially exposed or susceptible subpopulation, without consideration of costs or other nonrisk factors. EPA has determined that specific conditions of use of HBCD present an unreasonable risk of injury to health or the environment. For those conditions of use for which EPA has found an unreasonable risk, EPA must take regulatory action to address that unreasonable risk through risk management measures enumerated in TSCA. EPA has also determined that specific conditions of use do not present unreasonable risk of injury to health or the environment. For those conditions of use for which EPA has found no unreasonable risk to health or the environment, the Agency’s determination is a final Agency action and is issued via order in the risk evaluation. ADDRESSES: The docket for this action, identified by docket identification (ID) number EPA–HQ–OPPT–2019–0237, is available online at https:// www.regulations.gov or in-person at the Office of Pollution Prevention and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566–1744, and the telephone number for the OPPT Docket is (202) 566–0280. Due to the public health concerns related to COVID–19, the EPA Docket Center (EPA/DC) and Public Reading Room is closed to visitors with limited exceptions. The EPA/DC staff continue to provide remote customer service via email, phone, and webform. For the latest status information on EPA/DC services and docket access, visit https:// www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: For technical information contact: Dr. Stan Barone, Office of Pollution Prevention and Toxics (7403M), Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; SUMMARY: ENVIRONMENTAL PROTECTION AGENCY PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 telephone number: (202) 564–1169; email address: barone.stan@epa.gov. For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@ epa.gov. SUPPLEMENTARY INFORMATION: I. General Information A. Does this action apply to me? This action is directed to the public in general. This action may be of interest to persons who are or may be interested in risk evaluations of chemical substances under TSCA, 15 U.S.C. 2601 et seq. Since other entities may also be interested in this final risk evaluation, the EPA has not attempted to describe all the specific entities that may be affected by this action. B. What is EPA’s authority for taking this action? TSCA section 6, 15 U.S.C. 2605, requires EPA to conduct risk evaluations to ‘‘determine whether a chemical substance presents an unreasonable risk of injury to health or the environment, without consideration of costs or other nonrisk factors, including an unreasonable risk to a potentially exposed or susceptible subpopulation identified as relevant to the risk evaluation by the Administrator, under the conditions of use.’’ 15 U.S.C. 2605(b)(4)(A). TSCA sections 6(b)(4)(A) through (H) enumerate the deadlines and minimum requirements applicable to this process, including provisions that provide instruction on chemical substances that must undergo evaluation, the minimum components of a TSCA risk evaluation, and the timelines for public comment and completion of the risk evaluation. TSCA also requires that EPA operate in a manner that is consistent with the best available science, make decisions based on the weight of the scientific evidence and consider reasonably available information. 15 U.S.C. 2625(h), (i), and (k). TSCA section 6(i) directs that a determination of ‘‘no unreasonable risk’’ shall be issued by order and considered to be a final Agency action, while a determination of ‘‘unreasonable risk’’ is not considered to be a final Agency action. 15 U.S.C. 2605(i). The statute identifies the minimum components for all chemical substance risk evaluations. For each risk evaluation, EPA must publish a document that outlines the scope of the risk evaluation to be conducted, which includes the hazards, exposures, conditions of use, and the potentially E:\FR\FM\25SEN1.SGM 25SEN1

Agencies

[Federal Register Volume 85, Number 187 (Friday, September 25, 2020)]
[Notices]
[Page 60456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21143]



[[Page 60456]]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-10015-06-OA]


Notice of Meeting of the EPA Children's Health Protection 
Advisory Committee (CHPAC)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the provisions of the Federal Advisory Committee 
Act, notice is hereby given that the next meeting of the Children's 
Health Protection Advisory Committee (CHPAC) will be held virtually 
October 22, 2020. The CHPAC advises the Environmental Protection Agency 
(EPA) on science, regulations and other issues relating to children's 
environmental health.

DATES: October 22, 2020 from 2 p.m. to 5 p.m.

ADDRESSES: The meeting will take place virtually. If you want to listen 
to the meeting or provide comments, please email [email protected] for 
further details.

FOR FURTHER INFORMATION CONTACT: Nica Louie, Office of Children's 
Health Protection, U.S. EPA, MC 1107T, 1200 Pennsylvania Avenue NW, 
Washington, DC 20460, (202) 564-7633 or [email protected].

SUPPLEMENTARY INFORMATION: The meetings of the CHPAC are open to the 
public. An agenda will be posted to https://www.epa.gov/children/childrens-health-protection-advisory-committee-chpac.
    Access and Accommodations: For information on access or services 
for individuals with disabilities, please contact Nica Louie at 202-
564-7633 or [email protected].

    Dated: September 16, 2019.
Nica Mostaghim,
Environmental Health Scientist.
[FR Doc. 2020-21143 Filed 9-24-20; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.